The Society for Immunotherapy of Cancer (SITC) hosted "Session 303: Hot Topic Symposium: When Phase III Trial Results Diverge from Phase II Data – An Analysis of Recent Trials in Immuno-Oncology" during the 37th Annual Meeting & Pre-Conference Programs on November 12, 2022. Available here are the presentation slides and video from the session, as permitted by presenters.
The audience includes basic and clinical investigators from academic institutions, industry and regulatory agencies, including clinicians, basic and translational researchers, graduate students, post-doctoral fellows, and allied health professionals involved in cancer research as well as pharmacists and payers, who wish to learn more about cancer immunology and immunotherapy and its incorporation into current (and future) effective cancer treatment.To view the entire program schedule (including presenter permission to post) please click here.
SITC 2022 Annual Meeting: Saturday, November 1201:30:52